Life sciences venture capitalist Vesalius Biocapital III has announced the final close of the VBC III fund at €120m.
Scientists from the University of Washington are using the Phenoglyphs machine learning module to achieve faster high-content analysis through automation and simplification.
Spotlight: Proactive Biomarker Planning to Optimize Clinical Trials
Oncology drugs developed through a biomarker-guided precision medicine design are 38% more likely to be commercialized. But success relies on following a plan from the start - learn how in this free whitepaper.
Exclusively designed for stakeholders within the diagnostics and research tool industry.
Always on the first day of MEDICA® in Dusseldorf!